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Abstract
Understanding the dynamical evolution of cancer, with the final goal
of developing effective techniques for diagnosis, prediction and treatment
is one of the main challenges of modern biosciences. In this paper we
approach the temporal ordering reconstruction problem, which refers to
the temporal sorting of a collection of static biological data. The solu-
tion of this problem may help in better understanding the key principles
and properties of the disease progression. By using a previously proposed
technique for extracting temporal progressions from cross-sectional cancer
gene expression data, we develop a novel methodology to be applied to
static cross-sectional copy number alterations, and we test it on patients
diagnosed colorectal cancer at different stages. To capture distinct aspects
of this complex phenomenon, we define several measures of chromosomal
alterations and filters targeting significant portions of chromosomes. Re-
sults obtained with various measures and filters highlight the best setting
for the problem, the most relevant chromosomal alterations and empha-
size the influence that copy number alterations hitting key genes may have
on the development of the disease.
Keywords: Colorectal cancer, Copy number alterations, Temporal or-
dering, Cancer progression.
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1 Introduction
Cancer is a complex disease caused by different factors and events, mostly affect-
ing the dynamics of the gene regulatory networks and of the signaling pathways
that normally rule the correct functioning of cells, tissues and organs. As such,
understanding and characterizing cancer dynamics and development is one of
the big challenges of modern biosciences, in conjunction with the development
of suitable and effective techniques for diagnosis, prediction and treatment. To
this end, the collection and the in-depth analysis of experimental biological data
is fundamental in order to validate theories and models, both from the quali-
tative and the quantitative point of view, and to foster the formulation of new
hypotheses and experimental directions.
Yet, even though the amount of cancer-related data publicly available in
the various databases is nowadays huge [The Cancer Genome Atlas Network
(2016)], the challenge is now to deal with the dynamical characterization of
such a complex phenomenon. Therefore, extracting useful information about
cancer progression (i.e., a form of “dynamical” information) from “static” bio-
logical data would have a major significance and impact on the related research.
This paper approaches the “temporal ordering reconstruction problem” (tor),
that is the sorting of a collection of multi-dimensional biological data to reflect
an accurate temporal progression of the target disease. Despite being a general
statement problem, we restrict it to considering Copy Number Alteration (CNA)
data from a set of patients at different stages of the disease and, in particular,
we focus on the case of colorectal cancer progression. There are few studies that
approach various forms of the tor problem using various types of data but,
to the best of our knowledge, CNA data has not been used to solve the tor
problem as defined above, i.e., to reconstruct the temporal ordering of a given
set of samples [Desper et al. (1999), Pathare et al. (2009)].
Colorectal cancer. Colorectal cancer (CRC) is the third most common type
of cancer worldwide and the second most frequent cause of cancer-related death
[Jemal et al. (2010)]. Most CRCs develop through a series of distinct morpholog-
ical stages that are strongly correlated with the malfunctioning of the complex
signaling networks ruling the intestinal crypt dynamics and homeostasis, which
is induced by the accumulation of alterations in the function of key regula-
tory genes and genetic instability [Vogelstein et al. (1988), Fearon & Volgestein
(1990), Kinzler & Vogelstein (2002), Frank (2007), Jass (2007), Medema & Ver-
mulen (2011), The Cancer Genome Atlas Network (2012)]. In particular, three
major forms of genetic instability in CRC have been described: microsatellite
instability, epigenetic changes, e.g. DNA methylation, and chromosomal insta-
bility. These happen in 13 %, 40 % and 47 % of the cases, respectively [Ashktorab
et al. (2010)]. Chromosomal instability is associated with a poorer prognosis
than that in patients with microsatellite instability [Walther et al. (2009)]. The
chromosomal instability usually implies gains and losses of segments of chromo-
somes.
In the “standard progression”, which covers around the 60% of the cases,
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the disease progression crosses a few major phenotypic stages, i.e., adenoma,
carcinoma and metastasis, through a number of intermediated phases and minor
events. The samples and data that we have analyzed so far were classified
by pathologists, using histological analysis, according with the standard four
stages classification for CRC: the first one being the least severe and the fourth
implying cancer metastasis [Reid et al. (2009)].
Copy number alterations. Chromosomal CNAs refer to regions of the DNA
that have either been deleted or duplicated a certain number of times on chromo-
somes. These aberrations may affect the function of certain genes, modifying
their expression and have been associated with susceptibility or resistance to
certain diseases. In cancer, chromosomal CNAs can also lead to activation of
oncogenes and inactivation of tumor suppressor genes. Mutation or deletion,
generally of both copies, leads to inactivation of tumor suppressor genes, while
oncogenes become active through mutation or amplification, usually of one copy
[Sheffer et al. (2009)]. These CNAs can be as large as numerical anomalies of
entire chromosomes, or as small as segmental amplification or deletion of less
than 10 kb. Although a preferred order for the genetic alterations in CRC pro-
gression exists, the total accumulation of CNAs rather than their order is likely
most important [Fearon & Vogelstein (1990)].
A comprehensive picture of chromosomal gains and losses during the progres-
sion from high-grade adenomas to invasive carcinomas is found in CRC tumors
[Ried et al. (1996), The Cancer Genome Atlas Network (2012)]. One class of
genetic alterations involves mutations of oncogenes and tumor-suppressor genes
that directly control cell birth and death, such as APC, KRAS, and p53 [Shen
et al. (2007)]. The chromosome 7 amplification, which is also observed in some
colon adenomas, occurs at early stages of colorectal tumor progression [Bomme
et al. (1994)]. During the progression from high-grade adenomas to invasive
carcinomas, other specific chromosomal aberrations become common, such as
gains on 8q, 20q, 7, 13 and deletions on 8p, 17p,18q,15q and 20q [Ashktorab
et al. (2010)].
State of the art. The tor problem is general and can be approached from
different, often complementary, perspectives. The Machine Learning and Data
Mining communities pose the general problem as “parallel” to the standard
classification one; some studies have shown that the general problem is NP -
complete [Cohen et al. (1999), Ramakrishnan et al. (2009)].
In Computational Biology and in Bioinformatics we can distinguish at least
two complementary lines of work. On one side, the tor problem is framed as
the task of re-ordering, according to some “logic”, a set of independent quanti-
tative “observations” of a phenomenon. This version of the tor problem was
mostly studied with cross-sectional gene expression data as input [Magwene
et al. (2003), Gupta & Bar-Joseph (2008), Czibula et al. (2013), Guo et al.
(2014)]. On the other side, the tor problem can be framed as the problem of
inferring causal relations among the “observables” associated to the input obser-
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vations. This version of the problem was mainly studied within cancer research.
In this case CNA data extracted via, e.g., Comparative Genomic Hybridization,
is analyzed to understand which CNA is functional to cause other CNAs. The
mathematical techniques used to solve this problem span from tree-based in-
ference to Bayesian networks, and the driving logic relies on the accumulation
of CNAs in a progressing cancer [Desper et al. (1999), Pathare et al. (2009),
Gerstung et al. (2011), Beerenwinkel et al. (2005), Olde Loohuis et al. (2014),
Ramazzotti et al. (2015)].
Clearly, these two aspects of the tor problem are complementary: the for-
mer sorts the input observations, i.e. the samples, according to their profiles
of CNA alterations, while the latter defines causal models involving the events
associated to the input observations, i.e. the CNA alterations themselves. Both
versions of the tor problem are interesting, and their solutions can be used to
yield, together, a better comprehension of cancer in the form of, e.g., a CNA-
level classifier for profiles/accumulations.
In this preliminary work, we focus on the first of the two interpretations of
the tor problem, extending to CNAs the work on expression data by Gupta and
Bar-Joseph [Gupta & Bar-Joseph (2008)]. Albeit conceptually simple, the tech-
nique is effective and promising, and is based on the reduction of the sorting
problem to a well-known route-planning problem, under two biologically rea-
sonable assumptions over the data. We shall use this technique looking solely
to CNAs, rather than gene expression; in the next sections we will recall the
intuitions underlying this approach.
A different approach based on minimum spanning trees and PQ-trees is
introduced by Magwene et al. [Magwene et al. (2003)]. The minimum spanning
tree algorithm is applied on a weighted, undirected graph, in which nodes are
represented by multi-dimensional microarray data. These algorithms are tested
on artificial data sets, as well as on time-series gene expression data sets derived
from DNA microarray experiments.
Goals. Our work leverages the work of Gupta and Bar-Joseph, applied to CNA
data. In our analysis, we also provide a more fine grained look on the events
that may characterize a change in the progression profile; as it will become
clear in the paper, we look at a “segmentation” of the SNP data and not only
at chromosomal arms gains and losses [Daruwala et al. (2004)]. Finally, one
more goal we pursue is to provide a building block in an analysis pipeline that
can be used to look at temporal reconstruction problems that assume an already
(partially) ordered dataset [Ramakrishnan et al. (2010), Antoniotti et al. (2010)].
A preliminary version of this work was presented as a poster at NETTAB 2012,
Workshop on ’Integrated Bio-Search’ [Bocicor et al. (2012)].
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2 The Gupta and Bar-Joseph method for static
expression data
Gupta and Bar-Joseph [Gupta & Bar-Joseph (2008)] formally show that, under
a model of a single gene dynamics, the correct ordering of the static expression
data sets can be recovered by solving an instance of the Traveling Salesman
Problem (TSP).1
The approach by Gupta and Bar-Joseph is based on two key hypotheses:
(i) a gene driving a specific disease does not change the direction of its ex-
pression trajectory very often (i.e., its expression level either increases or
decreases);
(ii) at any time point, a gene will remain at the same expression level as the
previous time point with some probability.
Statement (i) means that a gene going up at a specific time point is likely to go
up or remain at the same level in the next time point. Thus, despite the fact
that a gene may change its expression trajectory directions multiple times, if
enough data is available then the probability of this event is
(1− p) < 1
2
,
where p is the probability that a gene will not change its direction between two
successive time points. This assumption is supported by some data sets where
very few genes change directions more than once, i.e. most genes responding to
the condition either go up and then down, or vice versa [Gasch et al. (2000),
Nau et al. (2002)].
Statement (ii), which subsumes a Markov interpretation of the process, is
formalized stating that a gene increases or decreases its expression level, de-
pending on its direction, with some probability 1 − q, thus it does not change
with probability q. In general, q should be small indicating that most genes do
not change in time.
Setting on these premises, the random variable
Z = 〈Z1(t), . . . , Zm(t)〉 (1)
is defined where Zi(t) is the expression of the i-th gene at time t [Gupta &
Bar-Joseph (2008)]. This variable models the expression of the set of genes
one wants to consider, m in this case, assumed to be independent. A one-step
theorem is then proved stating that, for all possible time steps t = 1, . . . , T , the
inequality
||Z(t+ 1)− Z(t)||1 < ||Z(t+ 2)− Z(t)||1 (2)
1This is the problem of determining the shortest possible route that visits, exactly once,
each one of a set of cities and returns to the origin city, given the list of distances between
each pair of cities. Since it is a NP-hard problem, algorithms to find approximate solutions
are often used [Applegate et al. (2003)].
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holds with probability at least 1−T e−O(m(1−q)). Here, the L1 metric || · · · ||1 is
used, i.e.
||x− y||1 =
n∑
i=1
|xi − yi|
for x,y ∈ Rn. Conditions for this inequality to hold are reasonable: q < 1, i.e.,
a gene has time-varying expression, and for p ∈ (1/2, 1], i.e., a gene is more
likely to maintain its expression direction in two consecutive steps. Under the
very same assumptions, this one-step theorem generalizes to
||Z(t+ 1)− Z(t)||1 < ||Z(t+ k)− Z(t)||1 (3)
which holds with probability at least 1− T 2e−O(m(1−q)), for k ≥ 2.
The reduction to the TSP problem proposed by Gupta and Bar-Joseph is as
follows (see the Appendix for details): a graph G = (N,E) is built where the
set of nodes N = {pi | i = 1, . . . , n} is composed by all the n gene expression
profiles input to the tor problem, i.e. the profiles pi we want to order. The
graph is strongly connected, i.e. any profile can precede any other in the tor
solution, and the entry pi,j of the matrix Π of distances is
pi,j = ||pi − pj ||1 (4)
for i, j = 1, . . . , n. When n  log T the unique TSP path reconstructs the
correct ordering with high probability.
The method was applied to 50 patients affected by glioma, showing a good
correlation with the survival times. By the tor solution an outperforming
classifier was also defined and key oncogenes identified [Gupta & Bar-Joseph
(2008)].
3 Methods
To use the Gupta-Bar-Joseph method on CNA, rather than expression data,
we must be sure that such data fulfill the hypotheses recalled in the previ-
ous section [Gupta & Bar-Joseph (2008)]. This is indeed the case, as out-
lined in some studies [Staub et al. (2006), Habermann et al. (2007), Shef-
fer et al. (2009), The Cancer Genome Atlas Network (2012)]. Among others,
Tsafrir et al. showed that changes in expression level of genes are correlated
to CNAs, suggesting that particular chromosomal regions are frequently gained
and overexpressed (e.g., 7p, 8q, 13q, and 20q) or lost and underexpressed (e.g.,
1p, 4, 5q, 8p, 14q, 15q, and 18) in primary colon tumors [Tsafrir et al. (2006)].
They also showed that these aberrations are absent in normal colon mucosa and
become more frequent as the disease advances. Reid et al. combining gene ex-
pression and CNA data, identified more precise selected aberrations altering the
expression of multiple genes involved in CRC development [Reid et al. (2009)].
Therefore, it is safe to assume that CNAs:
(i) span over genes that are important for CRC development;
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(ii) do not significantly change the alteration direction (i.e. gain/loss) very
often;
(iii) are not likely to significantly change between two successive time points.
Thus, we are assuming the same hypotheses by Gupta and Bar-Joseph, rephrased
in the context of CNAs, and their approach to solve the TOR problem can then
be used in this context as well.
We remark that the application of the technique here discussed to other types
of genomic data regarding, e.g., somatic mutations or epigenetic phenomena
(e.g., DNA methylation) could be sound, provided that the two key hypotheses
discussed in Sect. 2 are verified. However, the verification of these hypotheses
in different contexts is not straightforward. An in-depth discussion on how
proceeding to set up such context-dependent verification is a very interesting
problem per se and we will pursue it in a future work as we further develop the
underlying theory.
3.1 Measuring chromosomal alterations
Every input sample Sk is a 22-dimensional vector Sk = 〈v1, v2, . . . , v22〉 where vi
is (a measure of) the CNAs associated to the i-th chromosome2. Set S = {Sk |
k = 1, . . . , n} is our data set with n samples. Each value vi is a measure cap-
turing different aspects of CNAs; testing several measures allows to understand
which one performs best with respect to CRC progression, as done in other
studies concerning genetic instability [Paris et al. (2004), Herzog et al. (2006)].
Blaveri et al. used the fraction of genome altered, the number of whole
chromosome changes, the number of copy number transitions within a chromo-
some, the total number of chromosomes containing transitions, amplifications,
and deletions [Blaveri et al. (2005)]. The authors found that early-stage bladder
tumors differed significantly from late-stage tumors with respect to these mea-
sures. Peng et al. have not found significant difference in the average number
of loci with CNAs between early and late stage gastric carcinoma, while ampli-
fications were more common in advanced cancers than in early ones [Peng et al.
(2003)].
Thus, given this uncertainty, we decided to test measures which consider
separately deletions or amplifications, measures accounting for the actual values
of the alterations, or for the number of alterations. For chromosome k, our input
data is a multiset Ck = {xi ∈ N}. We term value of an alteration any of the
xi’s, and we term intensity of an alteration its distance from the expected value
2, i.e., |xi − 2|, accounting that two copies of a certain segment of DNA are
expected to be present. Given Ck we defined the measures in top of Table 1 by
aggregating deletions and amplifications. Intuitively, IAk weights how much a
CNA is amplified, VAk gives greater weight to the actual CNA value while NAk
simply counts the number of CNAs. The measures with the avg superscript are
2We do not consider the gender-linked chromosome, in order to avoid gender-related issues
[Andersen et al. (2007)].
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Measures aggregating deletions and amplifications (Ck)
measure type measure type
IAk =
∑
xi∈Ck
|xi − 2| intensity IAavgk = IAk/NAk Average of IAk
VAk =
∑
xi∈Ck
xi value VA
avg
k = VAk/NAk Average of VAk
NAk = |Ck| number
Measures for deletions solely (Dk)
measure type measure type
IDk =
∑
xi∈Dk
|xi − 2| intensity IDavgk = IDk/NDk average of IDk
VDk =
∑
xi∈Dk
xi value VD
avg
k = VDk/NDk average of VDk
NDk = |Dk| number
Measures for amplifications solely (Ak)
measure type measure type
IAmpk =
∑
xi∈Ak
|xi − 2| intensity IAmpavgk = IAmpk/NAmpk Average of IAmpk
VAmpk =
∑
xi∈Ak
xi value VAmp
avg
k = VAmpk/NAmpk Average of VAmpk
NAmpk = |Ak| number
Table 1: Chromosomal measures. Measures defined over CNAs: top panel
contains those aggregating deletions and amplifications, mid and bottom panels
separate deletions from amplifications.
simply the averaged analogous. For a set C5 = {3, 4, 3, 3, 3, 1} we have IA5 = 7,
VAk = 17 and NAk = 6, so IA
avg
k = 7/6 and VA
avg
k = 17/6.
We also considered measures separating amplifications from deletions, as
done in previous studies [Herzog et al. (2006), Paris et al. (2004)]. A deletion
happens when the CNA value is xi < 2, an amplification when xi > 2; thus we
define Dk = {xi < 2 | xi ∈ Ck} and Ak = {xi < 2 | xi ∈ Ck}. These two sets
yield the measures in the mid and bottom panels of Table 1, which have the
usual meaning.
3.2 Filtering the input data: recurrent and cancer-specific
genes
So far we processed any input xi, representing some alteration, without consid-
ering its absolute frequency in the data set S, or any a priori biological knowledge.
However, it could be that certain filters applied on S could lead us towards ob-
taining more accurate orderings. In particular, it is legitimate to argue that (i)
the most recurrent alterations and (ii) alterations in genome regions encoding
cancer-specific genes could be privileged to infer progression.
To define both (i) and (ii) we use information on the chromosomal regions
containing CNAs. Let Ixi be the interval to which alteration xi maps to, and
let no(Ixi ,S) be the number of occurrences of Ixi in data set S. Notice that
8
Delk Ampk
Delreck Amp
rec
k
Amprec+cdgkDel
rec+cdg
k
CNAreck
CNAk
CNArec+cdgk
Figure 1: Input data. Euler diagram representing the nine different input sets
and the relationships among them. Ck refers to CNAs for a specific chromosome
k, Dk and Ak respectively refer to deletions and amplifications for chromosome
k as well. Superscript indexes rec and cdg respectively refer to recurrent CNAs
and cancer driver gene-related CNAs. We remark that Creck ⊂ Crec+cdgk and the
corresponding holds for Dreck and Areck .
two alterations could belong to two (or more) partially overlapped intervals. As
no(Ixi ,S) increases that the DNA in Ixi contains CNAs in a larger number of
samples. Thus, for (i) it suffices to restrict Ck (or, analogously, Dk or Ak) to
Creck = {xi ∈ Ck | no(Ixi ,S) > δmin} .
For (ii) we consider both recurrent CNAs and CNAs which belong to intervals
of the DNA coding for the genes presented in Table 2 3. So, if G is the set of all
DNA intervals containing at least one cancer driver gene, then:
Crec+cdgk = Creck ∪ {xi | Ixi ∈ G} .
The chromosome measures defined in Table 1 can then be applied on these
filtered data sets. The data sets we discussed are graphically represented in
Figure 1.
4 Results
This section presents a performance evaluation and a discussion of the results
obtained by our technique. Tests were extensively performed on synthetic data,
real applications on two groups of patients diagnosed with CRC.
3These genes are listed in the “Atlas of Genetics and Cytogenetics in Oncology and Hema-
tology”, a database containing oncogenes, cytogenetics data, clinical entities in cancer and
cancer-prone diseases [Huret et al. (2001)].
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Gene Chr. Roles in promoting CRC
APC 5q21-22 Wnt is (de)activated to degrade the b-catenin oncoprotein.
P53 17p13 Responsible for cell-cycle arrest and a cell-death checkpoint.
MLH1
MSH2
MSH6
3p21.3
2p22-p21
2p16
Mutations associated with defective mismatch repair.
PMS2 7p22.2 Post-replication DNA mispairs correction.
AXIN2 17q23-q24 Regulation of the beta-catenin stability in the Wnt pathway.
STK11 19p13.3 Encodes a serine threonine kinase and regulates cell polarity.
PTEN 10q23.3 PI3K activation yielding cell-survival and apoptosis suppression.
BMPR1A 10q22.3 Involved in the BMP/TGF-beta pathway.
SMAD4 18q21.1 Mediates the TGFβ pathway suppressing epithelial cell growth.
MYH 1p34.1 Involved in oxidative DNA damage repair.
DCC 18q21.3 Netrin-1 receptor promoting apoptosis when netrin is low.
KRAS 12p12.1 Unchecked activity of signaling through MAPK and PI3K.
Table 2: Colorectal cancer driver genes. Driver genes which can be con-
sidered to select events relevant to colorectal cancer progression [Huret et al.
(2001), Markowitz & Bertagnolli (2009)].
4.1 Synthetic data
We evaluated the performance of our algorithm on a large set of synthetic data
with various size and affected by the presence of noise. Each data set is gen-
erated by the following procedure, which we shortly report here and discuss in
detail in the Appendix.
We hypothesize the existence of N disjoint life expectancy classes, and create
M samples “naturally” clustered for each class. A sample is a vector in which
every component represents the overall CNAs of a specific chromosome; its value
is randomly assigned according to the values common to the sample class. The
basic assumption that to a larger CNA magnitude corresponds lower survival
as a consequence of the disease progression, is fulfilled by defining a total order-
ing among classes. We make this synthetic data more realistic by including a
Binomial model of experimental error and intrinsic biological variability. This
is obtained in the form of a noise parameter p ∈ [0, 1]. With probability p any
CNA is assigned a random value, regardless of the class the sample belongs to
(e.g., if p = 0.1 around the 10% CNAs in each sample are purely random). The
goal of this analysis is to determine, as a function of p, the percentage of samples
that are misclassified by the method.
In Figure 2 we display the average and best performance of the algorithm
for different values of noise, number of chromosomes and number of samples for
each class, with respect to the L1 metric.4 As expected, the method correctly
orders the whole set of samples (error approx. 0, on average) when data is
“clean” (i.e., p = 0), and dramatically drops in performance for p ≥ 0.3. All
in all, this suggest that the method might fail when intense noise is expected,
4Results obtained with the Euclidean distance are generally worst than those obtained
with L1, for low noise values, and equivalent for high noise values (not shown).
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Figure 2: Performance on synthetic data. Average/minimum error ratio
for the reconstruction method. Noise is discretized and 100 synthetic data sets
with 10 life expectancy classes containing 25, 50, and 100 distinct samples are
created. Combinations of 15, 20 or 25 chromosomes are used.
11
Figure 3: Colorectal cancer - dataset 1. Copy number alterations for
dataset, divided by chromosome [Reid et al. (2009)]. Amplifications (or gains)
are represented in blue, while deletions (or losses) are represented in red.
which hints at the intrinsic difficulty of inferring an effective ordering in the
presence of noise.
4.2 Colorectal cancer - dataset 1
The first real life data set we used was taken from the study of Reid et al.
[Reid et al. (2009)]. It contains tissue specimens from 53 consecutive sporadic
CRCs, which we reduce to 44 since for 9 samples the stage of the tumor was
unknown. The samples were hybridized to Affimetrix GeneChipVR Human
Mapping 250K NspI (SNP arrays). Raw intensity CEL files of the SNP arrays
were processed with CNAG program v.2.0 to detect chromosomal CNAs, using
an unpaired reference of 44 HapMap normal samples [Nannya et al. (2005),
Reid et al. (2009)]. With this procedure we obtain a CNA value for each, per
chromosome. The CNAs for the whole set of samples are illustrated in Figure
3.
For each sample we are given a series of information, the most important
being the overall survival (i.e., the survival time following the moment when
samples were taken), the stage and the mutation status of certain oncogenes or
tumor suppressor genes, such as APC, KRAS and p53 [Shen et al. (2007)]. These
are summarized in Table 3. Notice that this data set contains only one sample
classified in stage I, which however is statistically significant to our data.5
Three types of tests were made, one on this whole data and two when data
5To detect whether this sample is an outlier and if it may perturb our analyses, we per-
formed Dixon’s Q test on two sets containing the number and the values of all alterations,
respectively. By a comparison we detected that this sample is not any less statistically relevant
than the others [Verma & Quiroz-Ruiz (2006)].
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# Stage Surv. Vogelgram
1 IV 6 A-K-T-C
2 II 102+ A-K-T-C
3 IV 12 A-K-T-C
4 II 97+ A-K
5 II 53+ T-C
6 IV 26 -
7 IV 4 A-K-T-C
8 IV 10 A-K-T
9 IV 16 T
10 IV - T
11 III 40 A-T-C
12 II 14+ A-T-C
13 IV 10 A-K
14 I 89+ T-C
15 IV 62+ A-K-C
16 III 6 T
17 II 61+ A-C
18 IV 2 C
19 IV 11 A-K-C
20 III 35+ A-K
21 III 1 A-C
22 IV 11 A-T
# Stage Surv. Vogelgram
23 III 53 A-K-C
24 IV 10 A-K-T
25 III 64+ A-K
26 IV 9 A-C
27 III 75+ -
28 IV 2 A
29 IV 7 A-K-T-C
30 IV 22 A-K-T
31 III 83+ A-K
32 IV 6 K-T
33 III 62 A
34 IV 36 A-K-C
35 IV 10 A-K
36 IV 36 A-C
37 II 93+ A-T
38 IV - A-K
39 II 31+ C
40 II 18+ A-K-T-C
41 IV 6 A-K-C
42 II 99+ K
43 III 65+ A-K-T-C
44 II 38 A-T-C
Table 3: Colorectal cancer - dataset 1. Clinical data of the CRC data
samples [Reid et al. (2009)]. The overall survival refers to months, Vogelgram
refers to the mutation of driver genes APC (A), KRAS (K), TP53 (T) and 18q
LOH (C).
were filtered, as mentioned in Section 3.2: (i) all CNAs, (ii) recurrent CNAs
and (iii) cancer driver genes and recurrent CNAs, which correspond to CNAk,
CNAreck and CNA
rec+cdg
k . For each of the three types of tests mentioned above,
we obtained a number of 30 different orderings: for each of the 15 types of
chromosome measures that we defined two orderings were obtained by using, in
turns, the L1 and Euclidean distances. CNAs were considered recurrent when
present in more than 5% of samples (δmin = 5) and 10%, for cases (ii) and (iii).
Results and discussion. The 90 orderings that we obtained are ranked ac-
cording to the squared deviation distance from the ideal ordering, which is the
one yielded by the decreasing rate of survival predicted (see the Appendix) [Reid
et al. (2009)].
In Figure 4 the box plots of the minimum distances, for all three types
of tests (i), (ii) and (iii), both for the L1 and Euclidean distances (a table
containing all the distances can be found in the appendix in Figure 6). It can
be observed that, while the distribution of the distance are similar, with median
values in the range 0.4 − 0.45, the lowest distance, i.e. the best ordering, is
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obtained (a) when CRC driver genes and recurrent CNAs are considered, (b)
when the average of the alteration values is considered and (c) when Euclidean
distance is used to build the TSP instance (see the Table in Fig. 6). This clearly
outlines the importance of combining biological knowledge with mathematical
techniques to achieve significant results, as one might expect.
The ordering is plotted in Figure 4 where its correlation with the survival
time is shown. Samples in the left half of the ordering indicatively belong to
patients with higher survival times, samples in the right half have lower survival
times. The average survival time of the rightmost half is 22 months, while of
the left half is 49. The data set contains two samples without survival time
that were marked by a black asterisk. The inconsistencies between the stage
and survival time are marked by either a red or a blue asterisk, respectively
indicating too high/too low survival time prediction. As mentioned above, the
algorithm determines the order without determining its initial sample, therefore
the solution is time-reversible and the starting sample is chosen according to the
biological knowledge [Gupta & Bar-Joseph (2008)]. All in all, we may observe
that for the best ordering there are considerably more samples in stages III and
IV in the right half (20 samples) than in the left one (13 samples). Also, the
number of samples in stages I and II in the left half (9 samples) surpasses the
one in the right half (2 samples). Thus, we can state that the order is, to a
certain degree, also compatible with the histological stage. We also remark that
the sample having stage I is positioned in the first place.
We tested different chromosomal measures: the best and second best or-
derings display rather similar distances (0.189 and 0.247), while the other 88
orderings have quite similar distances varying in the range 0.318–0.468. Still we
can conclude that, generally, amplifications or deletions considered separately
induce a better ordering when values, intensities and numbers are considered,
and regardless of the distance metrics. There are a few cases in which all
alterations yielded a better ordering. Differently, when averaged values and in-
tensities of all alterations are considered, a better ordering is obtained, for both
metrics. However, in a few cases the results separately obtained for deletions
or amplifications are better. Finally, on average it seems that the two distance
metrics yield quite similar orderings, the differences between them being very
small. Therefore, by looking at the performance of the algorithm on synthetic
data (Figure 2), we can hypothesize that the overall level of noise in the data
set might be either very small or very high.
4.3 Colorectal cancer - data set 2
We also tested the technique on a public CRC microarray dataset form the Gene
Expression Omnibus (GEO) database (GSE11417) [Edgar et al. (2002)]. Tumor
samples and paired normal tissues were hybridized to Affymetrix Mapping 50K
Xba 240 arrays [Kurashina et al. (2008)]. CNAs for each sample were obtained
between pairs of tumors and normal samples. Raw intensity CEL files of the
SNP arrays were processed with CNAG program, as for the first dataset.
The original data set consisted of 94 samples, but due to the fact that one of
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Stage Number of samples Stage Number of samples
I 3 III 37
II 45 IV 8
Table 4: Colorectal cancer - dataset 2. Clinical data of the CRC data
samples from the second dataset.
them did not have any CNAs, we excluded it from this analysis. As in the case of
the previous dataset, for each sample we are given the number of alterations, per
chromosome. Still, as opposed to the first dataset, here only the information
regarding the histological stages for each sample is provided (Table 4). As
the overall survival time is missing, to compute the best result, we used the
available information, i.e. the stages. We assumed that in an ideal ordering the
first samples should have the least advanced stage and that the stages increase
in the ordering such that the samples categorized in stage 4 are the last ones.
Thus, we computed the square deviation distance for an ordering by summing
up the distances between the position of each sample in the obtained ordering
and the interval where the same sample should be placed in, according to stage
information.
Results and discussion. Similarly to the previous experiment, we obtained
30 different orderings. Using the SDD as described above, we evaluated each of
these orderings. In Fig. 5 we show the box plots of the distances, whereas in the
table in Fig. 7 in the Appendix all the distances are shown. In this case the best
ordering in terms of this distance was obtained for the test taking into account
(a) the CRC driver genes and recurrent CNAs, with (b) the chromosome measure
values of alterations and (c) the L1 distance. We therefore remark that, as seen
previously, it is important to also look at biological information, in conjunction
with mathematical methods. Figure 5 illustrates the best ordering, plotted
against the histological stages. We notice that the number of samples having
stages I and II is higher for the left half (28 samples) compared to the right one
(20 samples). In addition, we observe the inverse tendency in what concerns
the samples in stages III and IV: there are less in the left half (19 samples),
compared to the right one (26 samples). Another interesting observation is that
all the samples having stage IV are correctly placed in the second half.
Also in this experiment all alterations proved to be more important than
just deletions or amplifications. The only difference is that here the values of
alterations lead to the best ordering, while before it was the average of these
values. As respects the two used distances, we remark that the minimum SDDs
are obtained for the L1 distance, but we must mention that on average, the
values of the SDDs obtained by using the L1 distance are only slightly dissimilar
from those recovered using the Euclidean distance (at most 5 · 10−1 units).
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5 Conclusions and Further Work
In this paper we have presented a particular solution for the temporal order-
ing reconstruction problem (TOR) as defined in Section 1; we have built our
approach on a previously proposed solution [Gupta & Bar-Joseph (2008)], by
adapting it to chromosomal copy number alterations (CNAs) data and we tested
it on two colorectal cancer (CRC) data set. To the best of our knowledge, our
work is the first to adapt the TSP approach to the TOR problem, in conjunction
with CNA data; other approaches using CNAs have been published, but in their
respect, we have actually implemented a finer control over the genome regions
where CNAs actually appear.
In order to capture different features of the complex copy number alteration
phenomenon and to detect the most relevant with respect to our objectives,
we defined and used: (i) several chromosome-related measures, i.e., the inten-
sity, the values and the number of the overall alterations, the deletions and the
amplifications (and their corresponding averaged versions); (ii) distinct filters
targeting significant portions of chromosomes to be considered in the analysis,
i.e., recurrent CNAs and cancer driver genes-related CNAs; and (iii) different
distance metrics, i.e., Euclidean distance and L1 distance. The various combi-
nations of these distinct criteria result in a large number of different optimal
orderings, according to the specific measures, filters and metrics used.
With respect to the considered data sets, two sets of patients affected by
CRC at different progression stages, the validation was achieved by using the
quantitative (yet clearly partially arbitrary) measures of overall survival (or life
expectancy) or the histological stages (where the overall survival was not avail-
able). The techniques based on the values (and average values) of alterations
of both the recurrent and cancer-driver genes-related CNAs proved to outper-
form all the other techniques, pointing at a the dramatic influence that the
chromosome-related alteration of some key genes has on the development of the
disease (and on the related life expectancy).
Regarding the first CRC data set, we must remark that since it is somehow
not completely coherent (i.e., some patients characterized by advanced stages
of the CRC progression were labeled with long life expectancies and vice versa),
the best ordering with respect to the overall survival cannot be optimal with
respect to the histological classification as well. We believe that is most likely
due, on the one hand, to the scarce number of samples in our data set and,
on the other hand, to the “hidden factors" that lucidly influence the survival
expectancy and that were not considered in the analysis (e.g., age, gender, etc.).
Nevertheless, this outcome does not discredit the validity, the efficiency and
the general applicability of the methodology.
As for future development of the present work, the first problem that we will
address in deeper detail will be the issue of noise, given the limited robustness
of the method with respect to relatively noisy data, as one can see looking
at Figure 2. Secondly, we plan to extend the evaluation, by proposing new
chromosome-related measures. The copy number alterations are characterized
by several distinct features (e.g., segment length, number, type, position) while
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the measures we used are mostly univariate. Hence, extending the definitions of
the several chromosome-related measures, in order to capture a wider range of
characteristic properties, could lead to better and more accurate results. Last,
but not least, we will investigate how combining the presented approach with
classification algorithms influences the results: after the samples are classified,
the algorithm could be applied in order to obtain a partial temporal ordering
for each class and thus reconstruct the final ordering.
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A Appendix
A.1 Solving a TSP instance
The standard formulation of the TSP problem, requires a TSP-solver to re-
trieve, from a starting city, the shortest path visiting each city exactly once
and then returning to the original city. The route is determined by a graph-
like representation of the cities and the available routes. In graph theory this
is equivalent to finding the Hamiltonian cycle with the least weight, given a
complete weighted graph.
Here cities are represented by the samples, and a distance matrix is used to
define the distances between any two samples. Two types of metrics are used
to determine an overall distance between two vector samples: the L1 distance
|| · ||1 introduced in Section 2
||x− y||1 =
n∑
i=1
|xi − yi| ,
and the Euclidean distance || · ||
||x− y|| =
n∑
i=1
√
(xi − yi)2
with x,y ∈ Rn. With n samples, given that each chromosomal measure and
both the Euclidean or the L1 distances are independent of n, building such a
matrix has a time complexity of Θ(n2).
As shown in Section 2, the work that we used as a starting point for our
methodology introduces theorems stating that the unique TSP path reconstructs
the correct ordering with high probability, theorems that are proved for the L1
distance [Gupta & Bar-Joseph (2008)]. Still, the Euclidean distance is widely
used to describe (dis)similarities between genetic data, therefore we chose to
use it as well. We also aim at comparing the results obtained with each type of
metric in order to decide whether one is more suitable than the other for CNA
data.
As in both cases the obtained distance matrices are symmetric, the problem
is reduced to a symmetric version of the TSP. Nonetheless, it is clear that in
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our case the first and the last samples in the ordering should be distant from
each other (i.e., the distance between their representing vectors should be large),
considered the underlying hypotheses on copy number alterations described in
the previous sections. Consequently, we solve the Open TSP, which searches for
the shortest route that visits each city exactly once, but without returning to the
origin city. The equivalent problem in graph theory is to find the Hamiltonian
path having the minimum weight in an undirected complete weighted graph.
We used the Concorde tool to approximate the TSP solution [Applegate
et al. (2003)]. This software for the symmetric TSP combines linear program-
ming and cutting planes to solve the instance, and has been used to obtain the
optimal solutions to the full set of 110 TSPLIB instances [Cook (2011)]. The
Concorde TSP Solver [Applegate et al. (2003)] solves the classical TSP. There-
fore, we convert our Open TSP into a classical one by specifying exactly the
starting node for the path, and by adding a supplementary “fake” node with dis-
tance zero to the first node and very large distance in relation to all other nodes.
Then, the solution returned by the Concorde TSP Solver will be the cycle be-
ginning and ending with the “fake” node. As soon as this node is removed from
the solution, we obtain a non-cyclic path, representing the temporal ordering.
However, as we do not know a priori which sample should be the first in the
ordering, we try all of them and in the end, we choose the ordering that has the
minimum cost of the path (i.e., minimum sum of distances between samples).
The order of samples obtained by Concorde will be, with high probability,
the correct temporal ordering reflecting cancer progression, retrieved by using
CNA data.
A.2 Synthetic data
We hypothesize the existence of N life expectancy classes Ci, i = 1, . . . , N , the
first class C1 denoting the highest life expectancy and CN the shortest one. We
then create a set of M samples Sm, m = 1, . . . ,M belonging to each class. A
sample is again a j-dimensional vector V SmCi in which every value represents the
overall CNAs of a specific chromosome and j is the number of the considered
chromosomes. Every (integer) value of each vector is generated with uniform
probability with respect to disjoint value ranges for the distinct classes (e.g.,
[0, 5], [5, 10], [10, 15], ...), being the values in V SmC1 , in the lower range and those
in V SmCN , in the higher range. The assumption that a larger CNA magnitude
implies a lower survival rate as a consequence of the more advanced disease
progression, is therefore fulfilled. Notice that the range of values assigned to
each class is arbitrary, and the goal is to design an “ideal” data set P in which
the N ·M samples are naturally clustered according to the N classes.
We introduce noise as a parameter p ∈ [0, 1] representing the probability
that to a single entry in a sample is assigned a random value among all classes,
with uniform probability. This introduces, in each sample, a number of “noisy”
CNAs following a Binomial distribution B(j, p). Thus, we build from P a noisy
data set Pp. For instance, if p = 0.1 around the 10% CNAs are random and
hence incompatible with the expected life expectancy for the sample class. Here
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we introduced a noise as a model of potential measurement errors and intrinsic
biological variability.
We discretized p in [0, 0.5] and, for each of its values, we created 100 differ-
ent synthetic data sets with 10 different life expectancy classes containing 100
distinct samples. Besides, we considered data sets with three distinct numbers
of chromosomes, i.e. j = 15, 20, 25. As performance we measure the accuracy of
the obtained temporal ordering, e, as the average number of samples correctly
classified in each class, and we consider equivalently ordered samples within
each class. By averaging ensembles of executions of our algorithm we measure
the performance variation for increasing values of p.
A.3 Evaluating ordering against predicted survival
Given that a number of different orderings is obtained for each dataset, we
need a way to rank them to obtain the optimal one. We use the survival time
(or overall survival) following the moment in which the samples were taken,
under the assumption that the amount of CNAs and the progression of the
disease are correlated (which intuitively results in a overall shortening of the life
expectancy). Therefore, we operate as follows. We compute the “ideal ordering”
by sorting all the samples for decreasing life expectancy, and we pick as ideal
the ordering which is more similar to such an ordering.
Similarity is measured as the squared deviation distance (sdd) among the
sequences [Sevaux & Sorensen (2005)]. For each sample, the difference between
its actual and the expected position is computed. The sdd is the sum of the
squared values of these differences, for all samples. Thus, for any two orderings
pi and pi′, the sdd is
sdd(pi, pi′) =
n∑
k=1
(i− j)2, (5)
where pi(i) = pi′(j) = k, and i, j ∈ {1, . . . , n}. Here i, j are the positions of
sample k in the two permutations and n is the number of samples.
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Figure 4: Colorectal cancer - dataset 1. Top: the best ordering predicted
is plotted against both the histological stages (I–IV), and the overall survival
time. Leftmost samples have higher survival times, as expected. Colored stars
indicates (qualitative) mismatches between histological stage and survival time.
Bottom: the box plot of the (normalized) minimum squared deviation distance
(SDD) classified according to three cases: (C) all CNAs, (B) recurrent CNAs
and (A) cancer driver genes and recurrent CNAs, computed with either (a) L1
or (b) Euclidean metrics. The box plots are computed in each cases on the 5
distinct chromosomal measures in Table 1. All the distances are shown in the
table in Fig. 6 in the Appendix.
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Figure 5: Colorectal cancer - dataset 2. Top: the best ordering predicted is
plotted against both the histological stages (I–IV). No overall survival time is
available for this dataset. Bottom: the box plot of the (normalized) minimum
squared deviation distance SDDs classified according to three cases: (C) all
CNAs, (B) recurrent CNAs and (A) cancer driver genes and recurrent CNAs,
computed with either (a) L1 or (b) Euclidean metrics. The box plots are com-
puted in each cases on the 5 distinct chromosomal measures in Table 1. All the
distances are shown in the table in Fig. 6 in the Appendix.
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L1
 Simple Recurrent Recurrent + CDG
 CNA Amp Del CNA Amp Del CNA Amp Del
Values 0.449 0.446 0.408 0.462 0.445 0.344 0.441 0.423 0.452
Intensity 0.318 0.439 0.404 0.422 0.436 0.345 0.440 0.457 0.425
Number 0.442 0.439 0.415 0.392 0.428 0.346 0.448 0.432 0.449
Average values 0.406 0.438 0.453 0.356 0.460 0.352 0.247 0.404 0.441
Average intensities 0.378 0.417 0.431 0.394 0.460 0.453 0.402 0.452 0.393
       
Euclidean
 Simple Recurrent Recurrent + CDG
 CNA Amp Del CNA Amp Del CNA Amp Del
Values 0.400 0.349 0.418 0.406 0.440 0.424 0.447 0.442 0.391
Intensity 0.426 0.348 0.421 0.429 0.413 0.416 0.446 0.418 0.379
Number 0.415 0.424 0.419 0.398 0.422 0.422 0.464 0.372 0.388
Average values 0.412 0.468 0.400 0.334 0.335 0.400 0.189 0.439 0.400
Average intensities 0.320 0.403 0.394 0.397 0.359 0.444 0.337 0.433 0.447
Figure 6: Ranking the orderings - Dataset 1. Squared deviation distance
(SDD) obtained by using the different chromosome measures on the first CRC
dataset. Columns refer to (A) all CNAs, (B) recurrent CNAs and (C) cancer
driver genes and recurrent CNAs, divided in (1) all CNAs, (2) amplifications
or (3) deletions. Rows refer to the different used measures. The values in the
first table are computed with L1 distance, whereas in the second with Euclidean
distance.
1.
L1
Simple Recurrent Recurrent + CDG
CNA Amp Del CNA Amp Del CNA Amp Del
Values 0.227 0.146 0.195 0.261 0.164 0.167 0.134 0.138 0.232
Intensity 0.260 0.255 0.161 0.154 0.196 0.193 0.213 0.164 0.202
Number 0.194 0.186 0.161 0.201 0.238 0.218 0.224 0.221 0.212
Average values 0.238 0.193 0.208 0.166 0.310 0.243 0.245 0.204 0.218
Average intensities 0.190 0.211 0.215 0.227 0.193 0.221 0.282 0.135 0.172
Euclidean
Simple Recurrent Recurrent + CDG
CNA Amp Del CNA Amp Del CNA Amp Del
Values 0.249 0.247 0.181 0.212 0.210 0.235 0.231 0.244 0.192
Intensity 0.229 0.190 0.222 0.242 0.224 0.261 0.219 0.225 0.222
Number 0.171 0.257 0.204 0.277 0.230 0.237 0.190 0.184 0.216
Average values 0.198 0.193 0.230 0.176 0.209 0.273 0.233 0.258 0.224
Average intensities 0.143 0.209 0.197 0.194 0.264 0.214 0.198 0.261 0.245
Figure 7: Ranking the orderings - Dataset 2. SDD obtained by using the
different chromosome measures on the second CRC dataset. See the caption of
Fig. 1 for a detailed description of the table headers.
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